Articles
| Open Access |
DOI: THE USE OF ANTIBACTERIAL EYE OINTMENTS IN THE TREATMENT OF ACUTE AND CHRONIC DISEASES OF THE EYELIDS AND CONJUNCTIVA
Kakharova Dildora Maribjanovna , Andijan State Medical Institute, Uzbekistan Khoshimova Dilrabo Khoshimovna , Andijan State Medical Institute, Uzbekistan Nazarov Bakhtiyor Mamajonovich , Andijan State Medical Institute, Uzbekistan Madaminkhudzhaeva Dilafruz Kakhramonjon Qizi , Andijan State Medical Institute, UzbekistanAbstract
Currently, many studies are being carried out to study the effectiveness of ointment ophthalmic preparations. Ophthalmic ointments are unique in that they have a multicomponent mechanism of action. On the one hand, due to the ointment base, the effect of the medicinal substance itself is prolonged, and on the other hand, due to the structural features of the mucous membrane of the conjunctival cavity, these medicinal substances are very quickly absorbed. In the treatment of pathology of the ocular surface, including meibomyitis, barley and chalazion, preference is given to local therapy and ointment forms. The study was aimed at studying the effectiveness of antibacterial ophthalmic ointment of domestic production Tobrex - in the treatment of acute and chronic diseases of the eyelids and conjunctiva.
Keywords
Tobrex, conjunctiva, meibomyitis,
References
Brzheskij V.V., Egorova G.B., Egorov E.A. Dry eye syndrome and diseases of the eye surface: clinical course, diagnostics, treatment. M.: GEOTAR-Media, 2016:464 (in Russ.)]. Бржеский В.В., Егорова Г.Б., Егоров Е.А. Синдром «сухого глаза» и заболевания глазной поверхности: клиника, диагностика, лечение. М.: ГЭОТАР-Медиа, 2016:464
Rosenfield M. Computer vision syndrome: a review of ocular causes and potential treatments // Ophthalmic Physiol. Opt. 2011. Vol. 31 (5). P. 502–515.
American Optometric Association (AOA) [Электронный ресурс]. URL: http://www.aoa.org/patients-and-public/caring-for-your-vision/protecting-your-vision/computer-vision-syndrome (дата обращения 19.01.2016).
[
Article Statistics
Copyright License
Copyright (c) 2023 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.